The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prescription Gastrointestinal Drugs Market Research Report 2025
Synopsis
The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.
The global Prescription Gastrointestinal Drugs market was valued at US$ 28810 million in 2023 and is anticipated to reach US$ 41420 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prescription Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Gastrointestinal Drugs.
Report Scope
The Prescription Gastrointestinal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription Gastrointestinal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Gastrointestinal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
Segment by Type
Oral
Topical
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The prescription drugs are widely used in the treatment of gastrointestinal disorders, crohn’s disease, ulcerative colitis, irritable bowel syndrome, diverticular disease, constipation, celiac disease, short bowel syndrome, diarrhea, intestinal obstruction and digestive enzyme disorders.
The global Prescription Gastrointestinal Drugs market was valued at US$ 28810 million in 2023 and is anticipated to reach US$ 41420 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Prescription Gastrointestinal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Gastrointestinal Drugs.
Report Scope
The Prescription Gastrointestinal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prescription Gastrointestinal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Gastrointestinal Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Axcan Pharmaceuticals
Eisai
GlaxoSmithKline
Merck
Salix Pharmaceuticals
Segment by Type
Oral
Topical
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prescription Gastrointestinal Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prescription Gastrointestinal Drugs Market Overview
1.1 Product Overview and Scope of Prescription Gastrointestinal Drugs
1.2 Prescription Gastrointestinal Drugs Segment by Type
1.2.1 Global Prescription Gastrointestinal Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Topical
1.3 Prescription Gastrointestinal Drugs Segment by Application
1.3.1 Global Prescription Gastrointestinal Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Prescription Gastrointestinal Drugs Market Size Estimates and Forecasts
1.4.1 Global Prescription Gastrointestinal Drugs Revenue 2019-2030
1.4.2 Global Prescription Gastrointestinal Drugs Sales 2019-2030
1.4.3 Global Prescription Gastrointestinal Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prescription Gastrointestinal Drugs Market Competition by Manufacturers
2.1 Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prescription Gastrointestinal Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Prescription Gastrointestinal Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription Gastrointestinal Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Gastrointestinal Drugs, Product Type & Application
2.7 Prescription Gastrointestinal Drugs Market Competitive Situation and Trends
2.7.1 Prescription Gastrointestinal Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prescription Gastrointestinal Drugs Players Market Share by Revenue
2.7.3 Global Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prescription Gastrointestinal Drugs Retrospective Market Scenario by Region
3.1 Global Prescription Gastrointestinal Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prescription Gastrointestinal Drugs Global Prescription Gastrointestinal Drugs Sales by Region: 2019-2030
3.2.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2019-2024
3.2.2 Global Prescription Gastrointestinal Drugs Sales by Region: 2025-2030
3.3 Global Prescription Gastrointestinal Drugs Global Prescription Gastrointestinal Drugs Revenue by Region: 2019-2030
3.3.1 Global Prescription Gastrointestinal Drugs Revenue by Region: 2019-2024
3.3.2 Global Prescription Gastrointestinal Drugs Revenue by Region: 2025-2030
3.4 North America Prescription Gastrointestinal Drugs Market Facts & Figures by Country
3.4.1 North America Prescription Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prescription Gastrointestinal Drugs Sales by Country (2019-2030)
3.4.3 North America Prescription Gastrointestinal Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prescription Gastrointestinal Drugs Market Facts & Figures by Country
3.5.1 Europe Prescription Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prescription Gastrointestinal Drugs Sales by Country (2019-2030)
3.5.3 Europe Prescription Gastrointestinal Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Gastrointestinal Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Prescription Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prescription Gastrointestinal Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Prescription Gastrointestinal Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prescription Gastrointestinal Drugs Market Facts & Figures by Country
3.7.1 Latin America Prescription Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prescription Gastrointestinal Drugs Sales by Country (2019-2030)
3.7.3 Latin America Prescription Gastrointestinal Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription Gastrointestinal Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Gastrointestinal Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prescription Gastrointestinal Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prescription Gastrointestinal Drugs Sales by Type (2019-2030)
4.1.1 Global Prescription Gastrointestinal Drugs Sales by Type (2019-2024)
4.1.2 Global Prescription Gastrointestinal Drugs Sales by Type (2025-2030)
4.1.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2019-2030)
4.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2019-2030)
4.2.1 Global Prescription Gastrointestinal Drugs Revenue by Type (2019-2024)
4.2.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2025-2030)
4.2.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Prescription Gastrointestinal Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prescription Gastrointestinal Drugs Sales by Application (2019-2030)
5.1.1 Global Prescription Gastrointestinal Drugs Sales by Application (2019-2024)
5.1.2 Global Prescription Gastrointestinal Drugs Sales by Application (2025-2030)
5.1.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2019-2030)
5.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2019-2030)
5.2.1 Global Prescription Gastrointestinal Drugs Revenue by Application (2019-2024)
5.2.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2025-2030)
5.2.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Prescription Gastrointestinal Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Axcan Pharmaceuticals
6.2.1 Axcan Pharmaceuticals Corporation Information
6.2.2 Axcan Pharmaceuticals Description and Business Overview
6.2.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
6.2.5 Axcan Pharmaceuticals Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Salix Pharmaceuticals
6.6.1 Salix Pharmaceuticals Corporation Information
6.6.2 Salix Pharmaceuticals Description and Business Overview
6.6.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
6.6.5 Salix Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription Gastrointestinal Drugs Industry Chain Analysis
7.2 Prescription Gastrointestinal Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Gastrointestinal Drugs Production Mode & Process
7.4 Prescription Gastrointestinal Drugs Sales and Marketing
7.4.1 Prescription Gastrointestinal Drugs Sales Channels
7.4.2 Prescription Gastrointestinal Drugs Distributors
7.5 Prescription Gastrointestinal Drugs Customers
8 Prescription Gastrointestinal Drugs Market Dynamics
8.1 Prescription Gastrointestinal Drugs Industry Trends
8.2 Prescription Gastrointestinal Drugs Market Drivers
8.3 Prescription Gastrointestinal Drugs Market Challenges
8.4 Prescription Gastrointestinal Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Prescription Gastrointestinal Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Prescription Gastrointestinal Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Prescription Gastrointestinal Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Prescription Gastrointestinal Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Prescription Gastrointestinal Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Prescription Gastrointestinal Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Prescription Gastrointestinal Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Prescription Gastrointestinal Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Prescription Gastrointestinal Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prescription Gastrointestinal Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Prescription Gastrointestinal Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prescription Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Gastrointestinal Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prescription Gastrointestinal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Prescription Gastrointestinal Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Prescription Gastrointestinal Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Prescription Gastrointestinal Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Prescription Gastrointestinal Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Prescription Gastrointestinal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Prescription Gastrointestinal Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Prescription Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Prescription Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Prescription Gastrointestinal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Prescription Gastrointestinal Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Prescription Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Prescription Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Prescription Gastrointestinal Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Prescription Gastrointestinal Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Prescription Gastrointestinal Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Prescription Gastrointestinal Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Prescription Gastrointestinal Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Prescription Gastrointestinal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Prescription Gastrointestinal Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Prescription Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Prescription Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Prescription Gastrointestinal Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Prescription Gastrointestinal Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Prescription Gastrointestinal Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Prescription Gastrointestinal Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Prescription Gastrointestinal Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Prescription Gastrointestinal Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Prescription Gastrointestinal Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Prescription Gastrointestinal Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Prescription Gastrointestinal Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Prescription Gastrointestinal Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Prescription Gastrointestinal Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Axcan Pharmaceuticals Corporation Information
Table 76. Axcan Pharmaceuticals Description and Business Overview
Table 77. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product
Table 79. Axcan Pharmaceuticals Recent Developments/Updates
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Eisai Prescription Gastrointestinal Drugs Product
Table 84. Eisai Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Prescription Gastrointestinal Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Prescription Gastrointestinal Drugs Product
Table 94. Merck Recent Developments/Updates
Table 95. Salix Pharmaceuticals Corporation Information
Table 96. Salix Pharmaceuticals Description and Business Overview
Table 97. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product
Table 99. Salix Pharmaceuticals Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Prescription Gastrointestinal Drugs Distributors List
Table 103. Prescription Gastrointestinal Drugs Customers List
Table 104. Prescription Gastrointestinal Drugs Market Trends
Table 105. Prescription Gastrointestinal Drugs Market Drivers
Table 106. Prescription Gastrointestinal Drugs Market Challenges
Table 107. Prescription Gastrointestinal Drugs Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prescription Gastrointestinal Drugs
Figure 2. Global Prescription Gastrointestinal Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Prescription Gastrointestinal Drugs Market Share by Type in 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Prescription Gastrointestinal Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Prescription Gastrointestinal Drugs Market Share by Application in 2023 & 2030
Figure 8. Hospital Pharmacies
Figure 9. Online Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Global Prescription Gastrointestinal Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Prescription Gastrointestinal Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Prescription Gastrointestinal Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Prescription Gastrointestinal Drugs Average Price (USD/Unit) & (2019-2030)
Figure 15. Prescription Gastrointestinal Drugs Report Years Considered
Figure 16. Prescription Gastrointestinal Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Prescription Gastrointestinal Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Prescription Gastrointestinal Drugs Players: Market Share by Revenue in 2023
Figure 19. Prescription Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Prescription Gastrointestinal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Prescription Gastrointestinal Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Prescription Gastrointestinal Drugs Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Prescription Gastrointestinal Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Prescription Gastrointestinal Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Prescription Gastrointestinal Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Prescription Gastrointestinal Drugs Sales Market Share by Country (2019-2030)
Figure 45. Latin America Prescription Gastrointestinal Drugs Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Prescription Gastrointestinal Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Prescription Gastrointestinal Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Prescription Gastrointestinal Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Prescription Gastrointestinal Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Prescription Gastrointestinal Drugs by Type (2019-2030)
Figure 56. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Prescription Gastrointestinal Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Prescription Gastrointestinal Drugs by Application (2019-2030)
Figure 59. Global Prescription Gastrointestinal Drugs Price (USD/Unit) by Application (2019-2030)
Figure 60. Prescription Gastrointestinal Drugs Value Chain
Figure 61. Prescription Gastrointestinal Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
